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CASE REPORTS
Intimal sarcoma in an inflammatory aneurysm
after endovascular aneurysm repair
Nitin Garg, MBBS, MPH,a Mark A. Lewis, MD,b Joseph J. Maleszewski, MD,c and
Manju Kalra, MBBS,a Rochester, Minn
Long-term outcomes after endovascular aneurysm repair (EVAR) for inflammatory aneurysms are unknown. We present
a young patient with new-onset back pain and failure to thrive 6 years after EVAR for an inflammatory abdominal aortic
aneurysm (AAA). Endograft explanation was performed with a presumed diagnosis of infection. Pathology revealed
intimal sarcoma in the excluded aneurysm sac with liver metastasis. This report presents a detailed review of literature
regarding potential association of prosthetic implantation and carcinogenesis. ( J Vasc Surg 2012;55:1134-7.)
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nEndovascular aneurysm repair (EVAR) is recom-
mended for an inflammatory abdominal aortic aneurysm
(AAA) due to the high risk of injury to adjacent structures
with open surgery.1 Resolution of inflammatory changes
after EVAR has been described but long-term outcomes are
unknown and there is legitimate concern for increased
cancer risk in the setting of intense pre-existing inflamma-
tion.2,3 Inflammation creates a microenvironment favor-
able for tumor development, and some implanted devices
have carcinogenic potential.4 Herein, we present a case of
primary aortic intimal sarcoma in the aneurysm sac 6 years
after EVAR of an inflammatory aneurysm.
CASE REPORT
A 56-year-old man presented with a 4-month history of wors-
ening low back pain, radiating to bilateral groins. He had no
history of fever, chills, or night sweats, but had loss of appetite and
weight, and was unresponsive to steroid therapy. His medical
history was significant for hyperlipidemia, 50 pack-years of smok-
ing, and EVAR for an asymptomatic inflammatory AAA, with a
modular AneuRx graft (Medtronic, Minneapolis, Minn) placed at
another institution. He had no personal or family history of malig-
nancy or autoimmune disease. He was a manual laborer at a steel
plant with no high-risk sexual behavior or history of blood trans-
fusions.
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1134He was malnourished and ill-appearing, afebrile, in sinus
achycardia, but hemodynamically stable. Physical examination
as unremarkable with no external areas of tenderness or obvious
asses or lymphadenopathy.
Laboratory parameters revealed a normocytic anemia, mild
eukocytosis (12-14,000/mm3), thrombocytosis with a platelet
ount of 600,000/mm3, significantly elevated erythrocyte sedi-
entation rate of 120 to 140 mm/hour, and C-reactive protein of
200 mg/L.
Bone scintigraphy, bone marrow biopsy, and peripheral blood
mmunophenotyping revealed no malignancy. Esophagogas-
roduodenoscopy and colonoscopy were unremarkable except for
andida esophagitis. Multiple sets of blood cultures were negative
or bacteremia. Echocardiography showed intact ventricular func-
ion without valvular vegetations. Human immunodeficiency virus
erology and tumor markers were negative.
Serial computed tomography (CT) scan surveillance since the
VAR had shown resolution of periaortic inflammation and de-
reasing aneurysm sac size (Fig 1). Current CT scan revealed
ecurrent periaortic inflammation, enlargement of the aneurysm
ac, small persistent type II endoleak, and an irregular para-aortic
uid collection (Fig 1, D and E). A magnetic resonance imaging
can was noncontributory and 111Indium-labeled white blood cell
can showed no uptake to suggest infection, but it was postulated
hat thrombus in the aneurysm sac could have prevented white cell
enetration.
With a presumptive diagnosis of endograft infection, graft
xplantation, aortic debridement, and reconstruction with autoge-
ous femoral vein were planned. Abdominal exploration uncov-
red two small ulcerated lesions on the left lobe of the liver and
nlarged mesenteric lymph nodes. These lesions showed nonspe-
ific inflammation on frozen section. There was marked inflamma-
ion in the retroperitoneum and the duodenumwas densely adher-
nt to the aortic wall (Fig 2, A). A suprarenal aortic clamp was
pplied and the aneurysm sac was opened away from the duode-
um. No purulence or aortoenteric communication was encoun-
ered and Gram stain was negative for organisms. The endograft
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Volume 55, Number 4 Garg et al 1135was explanted and replaced with a rifampin-soaked bifurcated
Dacron graft conduit. Debridement of the luminal surface of the
very thickened and inflamed aneurysm sac was performed but all
specimens were negative for organisms. In an effort to find the
pathology, the small right para-aortic “fluid collection” was
searched for and explored (Fig 2, B). “Cheesy” necrotic material
was encountered which also revealed no organisms but atypical
cells suspicious for poorly differentiated malignancy. No other
lesions were found and omental wrap of the aortic graft was
performed. The patient tolerated the procedure well with resolu-
tion of his pain and anorexia.
Final pathology revealed poorly differentiated nonsmall cell
carcinoma in the aortic wall with an unusual spreading growth
pattern along the luminal surface (Fig 3). The tumor was localized
to the excluded aneurysm sac. No tumor was found in a biopsy of
the immediate infrarenal aortic wall. The same neoplasm was
identified in the liver, mesenteric lymph nodes, and periaortocaval
mass. Morphology and phenotype did not suggest a specific tissue
Fig 1. Serial computed tomography (CT) scan for post-e
postoperative follow-up demonstrating residual inflamm
years with decrease in aneurysm sac size to 4.8 cm from
endoleak (arrowhead) is demonstrated at 5-year follow-u
after onset of symptoms (D and E) demonstrating irregu
to inferior vena cava (IVC) (asterisk), and reappearance
compared to the preoperative site. The aneurysm sac hadof origin. Immunohistochemistry revealed the cells to be reactive cith CK7 and nonreactive with CK20, TTF-1, and Hepar. After
he patient left our institution, additional immunohistochemical
tudies revealed reactivity for CD31 and FLI-1 (Fig 3), supporting
mesenchymal neoplasm with aberrant keratin expression, and
pread along the aortic lumen was consistent with intimal sarcoma.
he patient continued to lose weight, was deemed ineligible for
hemotherapy on the basis of his performance status, and died 6
eeks after discharge.
ISCUSSION
Several reports of aortic intimal sarcomas arising in
ssociation with Dacron grafts have been published sug-
esting an inducing or promoting effect of foreign material
n the endothelium.5 Physical characteristics of the im-
lanted material, particularly pore size, are believed to be
mportant in tumorigenesis. The common characteristic of
umor-producing plastics in animal studies was a long-
ascular aneurysm repair (EVAR) follow-up. One-month
“halo” (arrow) (A), which is completely resolved at 3
in anteroposterior (AP) diameter (B). A small type II
with no change in sac size (C). A CT scan performed
uid collection abutting the aorta (small arrow), anterior
ammatory “halo” (E), although in a different location
eased in size to 6.3 cm in AP diameter.ndov
atory
5.4 cm
p CT
lar fl
of inflhain polymer structure.4 Dacron grafts are constructed
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ored with titanium dioxide. Although animal studies are
considered conclusive, the reported association between
grafts and tumor development in humans could be coinci-
dental.6 However, the clinical course in our report very
closely resembles another description of a patient with
high-grade epithelioid angiosarcoma of the aortic aneu-
rysm sac at site 5 years after repair with a VanGuard (Boston
Scientific/Scimed, Natick, Mass) endograft.7
Nickel and titanium alloys, commonly used in vascular
prosthesis, have been shown to induce carcinogenesis in
rodents.8,9 Nickel and titanium alloys promote an inflam-
matory response in soft tissue by activating human mono-
cytes10 and can change cellular vulnerability to extreme
temperatures, potentially signifying oncogenic alterations
Fig 2. Intraoperative photograph demonstrating the a
duodenum (A). Location of the para-aortic “fluid collec
Fig 3. Histology image of the tissue adherent to the
epithelioid cells with hyperchromatic and pleomorphic
eosin stain, 100 [A] and 200 [B]). Malignant cells ein antiapoptotic pathways.11 Thus, placement of endovas- aular stents in aneurysms that already demonstrate inflam-
ation may theoretically potentiate an existing predispo-
ition to vascular neoplasia, especially in younger
atients with stronger innate and adaptive immunity.12
ne plausible explanation could be pre-existing tumor in
he setting of intense inflammation in the original aneu-
ysm sac, analogous to a previous description of carotid
rtery leiomyosarcoma,13 although this has not been
escribed in inflammatory aortic aneurysms. Also, reso-
ution of the inflammatory response after EVAR, the
ong duration between EVAR and diagnosis of sarcoma,
nd usual rapid growth of these tumors would be incon-
istent with such a mechanism in our case.
Fewer than 200 primary aortic tumors have been de-
cribed in the literature since 1873.14 Intimal sarcomas,
inal aortic aneurysm (AAA) with a densely adherent
which proved to be high-grade intimal sarcoma (B).
graft that consists of infiltrating clusters of malignant
i and vague intracytoplasmic lumina (hematoxylin and
ting reactivity with (C) CD31 and (D) Fli-1 (200).bdomendo
nuclengiosarcomas, and leiomyosarcomas account for the vast
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to either the location of the tumor within the vessel wall or
an undifferentiated histologic type. Sarcomas that have a
mural location are more likely to have a specific pattern of
differentiation, most commonly smooth muscle (leiomyo-
sarcoma). Angiosarcomas, malignant neoplasms with en-
dothelial differentiation, may also arise as intimal/luminal
or mural masses. The CD-31 and Fli-1 immunohistochem-
istry can be useful in demonstrating vascular differentiation
in both histologic intimal sarcomas as well as angiosarco-
mas. The intimal/luminal tumors are more likely to narrow
the vessel lumen and embolize. The intimal histologic
subtype also portends a worse prognosis.15
Clinical presentation is variable and these neoplasms are
often confused with occlusive or aneurysmal atherosclerotic
lesions and can even present with rupture.16 However,
most patients receive attention for nonlocalized disease,
with metastases evident in70% at diagnosis with a dismal
median survival of 7 months.17
CT imaging of an aortic tumor often yields nonspecific
findings, including lack of generalized atherosclerosis.18,19
A magnetic resonance imaging or magnetic resonance an-
giography may show unusual contrast enhancement. Posi-
tron emission tomography scan may show increased uptake
in an occult tumor (not performed in our case), but fluo-
rodeoxyglucose avidity does not distinguish inflammation
from neoplasm.20 Overall, imaging seldom permits a pre-
operative diagnosis of malignancy and graft infection or
infectious aortitis is often presumed.7,16,21
Surgical resection is the definitive method for tissue
diagnosis and provides the only chance at long-term sur-
vival. The role of chemoradiation is unclear at this time.
CONCLUSIONS
Evidence for an association between EVAR of inflam-
matory aneurysms and intimal tumors arising at the site of
implantation is circumstantial at best. The time interval
between EVAR and tumor diagnosis may be theoretically
incompatible with induced sarcomagenesis, but the accrual
of more cases of primary aortic tumors in patients with a
history of EVAR should raise suspicion for a causal link.
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